Cargando…
Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer
Several members of the sirtuin (SIRT) family, a highly conserved family of NAD(+)-dependent enzymes, have been shown to play a critical role in both promoting and/or suppressing tumorigenesis. In this study, recent progress in the field concerning SIRT4 and cancer was reviewed, and the relationship...
Autores principales: | Huang, Guoyu, Zhu, Guanbao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001835/ https://www.ncbi.nlm.nih.gov/pubmed/29928130 http://dx.doi.org/10.2147/OTT.S157724 |
Ejemplares similares
-
Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer
por: Chen, Y, et al.
Publicado: (2014) -
Overexpression of SIRT4 inhibits the proliferation of gastric cancer cells through cell cycle arrest
por: Hu, Yiwang, et al.
Publicado: (2019) -
Sirtuin-3 (SIRT3), a Novel Potential Therapeutic Target for Oral Cancer
por: Alhazzazi, Turki Y, et al.
Publicado: (2011) -
Sirtuins (SIRTs) As a Novel Target in Gastric Cancer
por: Poniewierska-Baran, Agata, et al.
Publicado: (2022) -
SIRT4 is an independent prognostic factor in bladder cancer and inhibits bladder cancer growth by suppressing autophagy
por: Yin, Jie, et al.
Publicado: (2023)